Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.4.858PMID 11159508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.

  2000cited by this paper
• Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

  2000cited by this paper
• Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia.

  1999cited by this paper
• Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.

  1999cited by this paper
• The Risk of Recurrent Venous Thromboembolism in Carriers and Non-carriers of the G1691A Allele in the Coagulation Factor V Gene and the G20210A Allele in the Prothrombin Gene

  1999cited by this paper
• Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.

  1999cited by this paper
• Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.

  1999cited by this paper
• Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients.

  1999cited by this paper
• Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.

  1999cited by this paper
• The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

  1999cited by this paper
• A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

  1999cited by this paper
• Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

  1999cited by this paper
• The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).

  1997cited by this paper
• The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden

  1997cited by this paper
• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

  1996cited by this paper
• Inherited Thrombophilia*: Part 2

  1996cited by this paper
• Inherited Thrombophilia: Part 1

  1996cited by this paper
• The Long-Term Clinical Course of Acute Deep Venous Thrombosis

  1996cited by this paper
• Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency

  1996cited by this paper
• A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism

  1996cited by this paper
• Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.

  1995cited by this paper
• A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

  1995cited by this paper
• Cost-effectiveness analyses.

  1995cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.

  1994cited by this paper
• The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

  1994cited by this paper

• Risk factors for venous thromboembolism in Slovenian children and adolescents: a single center experience

  2026cites this paper
• Successful Use of Recombinant Tissue Plasminogen Activator in an Extremely Low Birth Weight Premature Infant for the Resolution of Multiple Thrombi

  2025cites this paper
• American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients

  2025cites this paper
• Thrombosis in Children: A Retrospective Study from a Single-center Database

  2024cites this paper
• The role of coagulation factors VIII, IX and XI in the prediction and mediation of recurrent thrombotic events in children with non-central venous catheter deep vein thrombosis.

  2024cites this paper
• Prothrombin G20210A mutation in Sudanese women with recurrent pregnancy loss

  2024cites this paper
• Extra-hepatic portal vein thrombosis in children: Single center experience

  2023cites this paper
• Thrombophilia testing in splanchnic venous thrombosis: Decoding a conundrum

  2023cites this paper
• High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.

  2023cites this paper
• Efficacy and Safety of Direct Oral Anticoagulants in Pediatric Venous Thromboembolism: A Systematic Review and Meta-Analysis

  2023cites this paper
• Thrombosis in the Neonatal Intensive Care Unit.

  2023cites this paper
• Catheter‐directed thrombolysis for massive deep vein thrombosis in an adolescent with severe antithrombin deficiency

  2022cites this paper
• Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study

  2022cites this paper
• Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia

  2022cites this paper
• International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis

  2021cites this paper
• Dual mutation (MTHFR A1298C with PAI (4G) mutation) manifesting with bilateral lower limb gangrene in a neonate

  2021cites this paper
• Benign Hematologic Disorders in Children: A Clinical Guide

  2021cites this paper
• Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature

  2021cites this paper
• In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence

  2020cites this paper
• The role of thrombophilia genes in the clinical implementation of arterial and venous thrombosis in newborns

  2020cites this paper
• Great Obstetrical Syndromes In G20210a Mutation Carriers Associated With High Prothrombin Activity

  2020cites this paper
• Thromboembolism

  2020cites this paper
• Acute Lymphoblastic Leukemia Presenting with Right Atrial Thrombosis and Massive Pulmonary Embolism: A Case Report

  2020cites this paper
• Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study.

  2020cites this paper
• Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity

  2020cites this paper
• Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the CHAT Consortium.

  2020cites this paper
• Lipoprotein (a): Principles from Bench to Bedside

  2020cites this paper
• Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.

  2019cites this paper
• Venous thromboembolism in childhood: where is Brazil after 20 years?

  2019cites this paper
• Thrombosis and Anticoagulation in Children

  2019cites this paper
• Recurrent deep vein thrombosis in children with malignant blood diseases: literature review

  2019cites this paper
• Insights into neonatal thrombosis.

  2019cites this paper
• Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

  2019cites this paper
• Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?

  2019cites this paper
• Thrombosis in children: Which test to whom, when and how much necessary?

  2018cites this paper
• Childhood Venous Thromboembolism in Yeungnam Region in Korea: Multicenter Study

  2018cites this paper
• Deep vein thrombosis in pediatric patients

  2018cites this paper
• Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design

  2018cites this paper
• Hemostasis in the Very Young

  2018cites this paper
• Neonatal Bleeding and Thrombotic Disorders

  2018cites this paper
• Idiopathic portal hypertension and extrahepatic portal venous obstruction

  2018cites this paper
• Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?

  2018cites this paper
• Thrombophilia testing in children: What and when should be tested?

  2018cites this paper
• Timetable Thursday , March 30 , 2017

  2017cites this paper
• Neonatal Venous Thromboembolism

  2017cites this paper
• 17 Thrombophilia in the young Hämostaseologie 1 – 2 / 2008 Thrombotic events in paediatric patients Locations

  2017cites this paper
• Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.

  2017cites this paper
• HowWeManage Pediatric DeepVenous Thrombosis

  2017cites this paper
• [Septic thrombus of the cavernous sinus].

  2017cites this paper
• Six Weeks Versus 3 Months of Anticoagulant Treatment for Pediatric Central Venous Catheter-related Venous Thromboembolism

  2017cites this paper
• Asymptomatic thrombosis following the use of central venous catheters in children

  2017cites this paper
• How We Manage Pediatric Deep Venous Thrombosis

  2017cites this paper
• Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?

  2017cites this paper
• The clinical features of alcohol use disorders in biological and step‐fathers that predict risk for alcohol use disorders in offspring

  2017cites this paper
• Outline: Pediatric Venous Thromboembolism

  2017cites this paper
• Incidence and characteristics of venous thrombotic events in pediatric cancer patients: A 20-year experience in the Maritimes, Canada

  2017cites this paper
• Anticoagulation Therapy in Children

  2017cites this paper
• Lipoprotein (a), the Metabolic Syndrome and Vascular Risk in Angiographied Coronary Patients.

  2016cites this paper
• Ultrasound Assisted Endovascular Thrombolysis in Adolescents: 2 Case Reports

  2016cites this paper
• Clinical features of registry-ascertained alcohol use disorders that reflect familial risk.

  2016cites this paper
• Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

  2016cites this paper
• THROMBOEMBOLIC DISEASE IN CHILDREN (EPIDEMIOLOGY, ETIOPATHOGENY AND DIAGNOSIS) (I)

  2016cites this paper
• Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

  2016cites this paper
• Natural history of deep vein thrombosis in children

  2015cites this paper
• Physiological, Pharmacological and Clinical Factors Associated with Thrombosis in Pediatric Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass

  2015cites this paper
• Safety update on the use of recombinant activated factor VII in approved indications.

  2015cites this paper
• Neonatal haemostasis and the management of neonatal thrombosis

  2015cites this paper
• Thrombosis in the Neonatal Intensive Care Unit.

  2015cites this paper
• Proteomic and other mass spectrometry based “omics” biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: Current state, unmet needs, and future directions

  2014cites this paper
• Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients

  2014cites this paper
• 54 T hrombosen und Thrombophilie

  2014cites this paper
• Thromboembolic Disorders in the PICU

  2014cites this paper
• Thrombosen und Thrombophilie

  2014cites this paper
• Intrauterine Upper Limb Ischemia: An Unusual Presentation of Fetal Thrombophilia—A Case Report and Review of the Literature

  2013influential citation
• Characteristics of abdominal vein thrombosis in children and adults

  2013cites this paper
• Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease

  2013cites this paper
• Pediatric thrombophilia.

  2013cites this paper
• Venous thromboembolism in neonates and children--update 2013.

  2013cites this paper
• Thromboembolic Outcomes Lemierre's and Lemierre's-Like Syndromes in Children: Survival and

  2013cites this paper
• Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives

  2013cites this paper
• Thrombophilia and varicella zoster in children

  2013cites this paper
• Effect of Factor V Leiden on Thrombosis in Childhood Leukemia

  2013cites this paper
• Management of Thrombotic Complications in Acute Lymphoblastic Leukemia

  2013cites this paper
• Venous thromboembolism in the paediatric patient

  2012cites this paper
• Imaging of perinatal stroke.

  2012cites this paper
• Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients

  2012cites this paper
• Clinical causes and treatment of the thrombotic storm

  2012cites this paper
• Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients

  2012influential citation
• Venous thromboembolism in neonates and children.

  2012cites this paper
• The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children

  2012cites this paper
• Management of neonatal thrombosis.

  2012cites this paper
• Pediatric Venous Thromboembolism

  2012cites this paper
• Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors

  2012cites this paper
• Health care expenditures associated with venous thromboembolism among children.

  2012cites this paper
• Antiphospholipid syndrome: Laboratory testing and diagnostic strategies

  2012cites this paper
• Current and future management of pediatric venous thromboembolism

  2012cites this paper
• Deep Vein Thrombosis: Thrombolysis in the Pediatric Population

  2012cites this paper
• Updates in thrombosis in pediatrics: where are we after 20 years?

  2012cites this paper
• Special considerations in vascular anomalies: hematologic management.

  2011cites this paper
• Guideline on the investigation, management and prevention of venous thrombosis in children *

  2011cites this paper